Delivery Order SPE2DR25D3301-SPE2DR26F19QF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,854.26 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count unit of use packaging) on December 9, 2025, with completion expected by December 10, 2025. This firm fixed-price delivery order is non-competitive and represents a single transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $45,395.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on September 24, 2025, with completion scheduled for September 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a $10,141.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with an ultimate completion date of December 16, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor and represents the type of medical supply procurement that supports military and federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a $36,129.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $41,291.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a completion date of December 9, 2025. The award, issued on December 8, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $73,325.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) with a completion date of June 2, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime...
- The Defense Logistics Agency awarded a $3,111.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count) on July 14, 2025, with completion due July 15, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $19,152.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit of use packaging). The contract was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,004.97 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging) on October 20, 2025, with completion scheduled for October 21, 2025. This non-set-aside award represents a standard pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order carries a ceiling value of $15,435.05 and is scheduled for completion by November 4, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, specifically supporting military and veteran...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19QFDelivery Order
The Defense Logistics Agency awarded a $61,350.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs within the federal medical procurement system. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. That prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, allowing AmerisourceBergen Drug Corp to serve customers including the Defense Health Agency and U.S. Coast Guard through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.4k | 12/15/25 |